世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

注射用フォサプレピタントジメグルミンの世界市場成長2024-2030年


Global Fosaprepitant Dimeglumine for Injection Market Growth 2024-2030

フォサプレピタントジメグルミンは、アプレピタントのホスホン酸プロドラッグであり、体内で速やかに加水分解を受けてアプレピタントに代謝される。主に催吐性の高い抗がん化学療法中に起こる悪心・嘔吐の治療に... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年11月12日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
117 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

フォサプレピタントジメグルミンは、アプレピタントのホスホン酸プロドラッグであり、体内で速やかに加水分解を受けてアプレピタントに代謝される。主に催吐性の高い抗がん化学療法中に起こる悪心・嘔吐の治療に使用される。
注射用フォスアプレピタント・ジメグルミンの世界市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年までの年平均成長率は%であると予測されています。
LPインフォメーション株式会社(東京都千代田区/代表取締役:劉克振、以下LPI)の最新リサーチレポート「注射用フォスアプレピタントジメグルミン(Fosaprepitant Dimeglumine for Injection)産業予測」は、2023年の注射用フォスアプレピタントジメグルミン(Fosaprepitant Dimeglumine for Injection)の世界総売上高を調査し、2024年から2030年に予測される注射用フォスアプレピタントジメグルミン(Fosaprepitant Dimeglumine for Injection)の売上高を地域別・市場分野別に包括的に分析しています。この調査レポートは、注射用フォスアプレピタントジメグルミンの売上高を地域別、市場分野別、サブセクター別に分類し、世界の注射用フォスアプレピタントジメグルミン産業の詳細な分析を掲載しています(単位:百万米ドル)。
この調査レポートは、世界の注射用フォスアプレピタントジメグルミンを包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また本レポートでは、注射用フォスアプレピタントジメグルミンのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析し、加速する世界の注射用フォスアプレピタントジメグルミン市場におけるこれらの企業の独自の地位をより良く理解しています。
この調査レポートは、注射用フォスアプレピタントジメグルミンの世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別の予測に分類して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の注射用フォスアプレピタントジメグルミンの現状と将来の軌道について非常にニュアンスのある見解を提供します。
注射用フォスアプレピタント・ジメグルミンの米国市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
注射用フォスアプレピタントジメグルミンの中国市場は、2023年の百万米ドルから2030年には百万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
注射用フォスアプレピタントジメグルミンのヨーロッパ市場は、2023年の百万米ドルから2030年には百万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
注射用フォスアプレピタントジメグルミンの世界的な主要プレイヤーは、Merck & Co、SPES PHARMACEUTICALS、Sungen Pharma、Hansoh Pharmaceutical、CTTQなどである。売上高では、世界の2大企業が2023年にほぼ%のシェアを占めている。
のシェアを占めている。
この調査レポートは、注射用フォスアプレピタントジメグルミン市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会を掲載しています。
タイプ別セグメント
先発医薬品
ジェネリック医薬品
用途別セグメント
病院
クリニック
その他
本レポートはまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
メルク・アンド・カンパニー
スペスファーマ
サンゲンファーマ
ハンソー製薬
CTTQ
斉魯製薬
洛新製薬
蒼彩康医薬
九元遺伝子工学
西濃生物製薬
セーロン製薬
本レポートで扱う主な質問
世界の注射用フォサプレピタントジメグルミン市場の10年見通しは?
注射用フォスアプレピタントジメグルミン市場の成長を促進する世界および地域別の要因は何か?
市場別、地域別で最も急成長する技術は何か?
注射用フォスアプレピタントジメグルミン市場の機会は最終市場規模によってどのように異なるのか?
注射用フォスアプレピタントジメグルミンのタイプ別、用途別の内訳は?



ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Country/Region, 2019, 2023 & 2030
2.2 Fosaprepitant Dimeglumine for Injection Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Fosaprepitant Dimeglumine for Injection Sales by Type
2.3.1 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Type (2019-2024)
2.4 Fosaprepitant Dimeglumine for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Fosaprepitant Dimeglumine for Injection Sales by Application
2.5.1 Global Fosaprepitant Dimeglumine for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Fosaprepitant Dimeglumine for Injection Breakdown Data by Company
3.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Company (2019-2024)
3.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Fosaprepitant Dimeglumine for Injection Revenue by Company (2019-2024)
3.2.2 Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Company
3.4 Key Manufacturers Fosaprepitant Dimeglumine for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fosaprepitant Dimeglumine for Injection Product Location Distribution
3.4.2 Players Fosaprepitant Dimeglumine for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Fosaprepitant Dimeglumine for Injection by Geographic Region
4.1 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Fosaprepitant Dimeglumine for Injection Sales Growth
4.4 APAC Fosaprepitant Dimeglumine for Injection Sales Growth
4.5 Europe Fosaprepitant Dimeglumine for Injection Sales Growth
4.6 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Growth
5 Americas
5.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country
5.1.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024)
5.1.2 Americas Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024)
5.2 Americas Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
5.3 Americas Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region
6.1.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region (2019-2024)
6.1.2 APAC Fosaprepitant Dimeglumine for Injection Revenue by Region (2019-2024)
6.2 APAC Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
6.3 APAC Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fosaprepitant Dimeglumine for Injection by Country
7.1.1 Europe Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024)
7.1.2 Europe Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024)
7.2 Europe Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
7.3 Europe Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection by Country
8.1.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fosaprepitant Dimeglumine for Injection
10.3 Manufacturing Process Analysis of Fosaprepitant Dimeglumine for Injection
10.4 Industry Chain Structure of Fosaprepitant Dimeglumine for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fosaprepitant Dimeglumine for Injection Distributors
11.3 Fosaprepitant Dimeglumine for Injection Customer
12 World Forecast Review for Fosaprepitant Dimeglumine for Injection by Geographic Region
12.1 Global Fosaprepitant Dimeglumine for Injection Market Size Forecast by Region
12.1.1 Global Fosaprepitant Dimeglumine for Injection Forecast by Region (2025-2030)
12.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Fosaprepitant Dimeglumine for Injection Forecast by Type (2025-2030)
12.7 Global Fosaprepitant Dimeglumine for Injection Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Merck & Co
13.1.1 Merck & Co Company Information
13.1.2 Merck & Co Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.1.3 Merck & Co Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck & Co Main Business Overview
13.1.5 Merck & Co Latest Developments
13.2 SPES PHARMACEUTICALS
13.2.1 SPES PHARMACEUTICALS Company Information
13.2.2 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.2.3 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 SPES PHARMACEUTICALS Main Business Overview
13.2.5 SPES PHARMACEUTICALS Latest Developments
13.3 Sungen Pharma
13.3.1 Sungen Pharma Company Information
13.3.2 Sungen Pharma Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.3.3 Sungen Pharma Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sungen Pharma Main Business Overview
13.3.5 Sungen Pharma Latest Developments
13.4 Hansoh Pharmaceutical
13.4.1 Hansoh Pharmaceutical Company Information
13.4.2 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.4.3 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hansoh Pharmaceutical Main Business Overview
13.4.5 Hansoh Pharmaceutical Latest Developments
13.5 CTTQ
13.5.1 CTTQ Company Information
13.5.2 CTTQ Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.5.3 CTTQ Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CTTQ Main Business Overview
13.5.5 CTTQ Latest Developments
13.6 Qilu Pharmaceutical
13.6.1 Qilu Pharmaceutical Company Information
13.6.2 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.6.3 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Qilu Pharmaceutical Main Business Overview
13.6.5 Qilu Pharmaceutical Latest Developments
13.7 Luoxin Pharmaceuticals
13.7.1 Luoxin Pharmaceuticals Company Information
13.7.2 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.7.3 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Luoxin Pharmaceuticals Main Business Overview
13.7.5 Luoxin Pharmaceuticals Latest Developments
13.8 Aosaikang Pharmaceutical
13.8.1 Aosaikang Pharmaceutical Company Information
13.8.2 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.8.3 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Aosaikang Pharmaceutical Main Business Overview
13.8.5 Aosaikang Pharmaceutical Latest Developments
13.9 jiuyuan gene engineering
13.9.1 jiuyuan gene engineering Company Information
13.9.2 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.9.3 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 jiuyuan gene engineering Main Business Overview
13.9.5 jiuyuan gene engineering Latest Developments
13.10 Sino Biopharmaceutical
13.10.1 Sino Biopharmaceutical Company Information
13.10.2 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.10.3 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Sino Biopharmaceutical Main Business Overview
13.10.5 Sino Biopharmaceutical Latest Developments
13.11 Sailong Pharmaceutical
13.11.1 Sailong Pharmaceutical Company Information
13.11.2 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.11.3 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sailong Pharmaceutical Main Business Overview
13.11.5 Sailong Pharmaceutical Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

Fosaprepitant dimeglumine is the phosphonate prodrug of aprepitant, which rapidly undergoes hydrolysis in the body to metabolize into aprepitant. It is primarily used to treat nausea and vomiting that occur during highly emetogenic anticancer chemotherapy.
The global Fosaprepitant Dimeglumine for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Fosaprepitant Dimeglumine for Injection Industry Forecast” looks at past sales and reviews total world Fosaprepitant Dimeglumine for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Fosaprepitant Dimeglumine for Injection sales for 2024 through 2030. With Fosaprepitant Dimeglumine for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fosaprepitant Dimeglumine for Injection industry.
This Insight Report provides a comprehensive analysis of the global Fosaprepitant Dimeglumine for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fosaprepitant Dimeglumine for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fosaprepitant Dimeglumine for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fosaprepitant Dimeglumine for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fosaprepitant Dimeglumine for Injection.
United States market for Fosaprepitant Dimeglumine for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Fosaprepitant Dimeglumine for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Fosaprepitant Dimeglumine for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Fosaprepitant Dimeglumine for Injection players cover Merck & Co, SPES PHARMACEUTICALS, Sungen Pharma, Hansoh Pharmaceutical, CTTQ, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Fosaprepitant Dimeglumine for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Original Drug
Generic Drug
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck & Co
SPES PHARMACEUTICALS
Sungen Pharma
Hansoh Pharmaceutical
CTTQ
Qilu Pharmaceutical
Luoxin Pharmaceuticals
Aosaikang Pharmaceutical
jiuyuan gene engineering
Sino Biopharmaceutical
Sailong Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Fosaprepitant Dimeglumine for Injection market?
What factors are driving Fosaprepitant Dimeglumine for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fosaprepitant Dimeglumine for Injection market opportunities vary by end market size?
How does Fosaprepitant Dimeglumine for Injection break out by Type, by Application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Country/Region, 2019, 2023 & 2030
2.2 Fosaprepitant Dimeglumine for Injection Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Fosaprepitant Dimeglumine for Injection Sales by Type
2.3.1 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Type (2019-2024)
2.4 Fosaprepitant Dimeglumine for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Fosaprepitant Dimeglumine for Injection Sales by Application
2.5.1 Global Fosaprepitant Dimeglumine for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Fosaprepitant Dimeglumine for Injection Breakdown Data by Company
3.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Company (2019-2024)
3.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Fosaprepitant Dimeglumine for Injection Revenue by Company (2019-2024)
3.2.2 Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Company
3.4 Key Manufacturers Fosaprepitant Dimeglumine for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fosaprepitant Dimeglumine for Injection Product Location Distribution
3.4.2 Players Fosaprepitant Dimeglumine for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Fosaprepitant Dimeglumine for Injection by Geographic Region
4.1 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Fosaprepitant Dimeglumine for Injection Sales Growth
4.4 APAC Fosaprepitant Dimeglumine for Injection Sales Growth
4.5 Europe Fosaprepitant Dimeglumine for Injection Sales Growth
4.6 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Growth
5 Americas
5.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country
5.1.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024)
5.1.2 Americas Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024)
5.2 Americas Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
5.3 Americas Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region
6.1.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region (2019-2024)
6.1.2 APAC Fosaprepitant Dimeglumine for Injection Revenue by Region (2019-2024)
6.2 APAC Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
6.3 APAC Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fosaprepitant Dimeglumine for Injection by Country
7.1.1 Europe Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024)
7.1.2 Europe Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024)
7.2 Europe Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
7.3 Europe Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection by Country
8.1.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fosaprepitant Dimeglumine for Injection
10.3 Manufacturing Process Analysis of Fosaprepitant Dimeglumine for Injection
10.4 Industry Chain Structure of Fosaprepitant Dimeglumine for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fosaprepitant Dimeglumine for Injection Distributors
11.3 Fosaprepitant Dimeglumine for Injection Customer
12 World Forecast Review for Fosaprepitant Dimeglumine for Injection by Geographic Region
12.1 Global Fosaprepitant Dimeglumine for Injection Market Size Forecast by Region
12.1.1 Global Fosaprepitant Dimeglumine for Injection Forecast by Region (2025-2030)
12.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Fosaprepitant Dimeglumine for Injection Forecast by Type (2025-2030)
12.7 Global Fosaprepitant Dimeglumine for Injection Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Merck & Co
13.1.1 Merck & Co Company Information
13.1.2 Merck & Co Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.1.3 Merck & Co Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck & Co Main Business Overview
13.1.5 Merck & Co Latest Developments
13.2 SPES PHARMACEUTICALS
13.2.1 SPES PHARMACEUTICALS Company Information
13.2.2 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.2.3 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 SPES PHARMACEUTICALS Main Business Overview
13.2.5 SPES PHARMACEUTICALS Latest Developments
13.3 Sungen Pharma
13.3.1 Sungen Pharma Company Information
13.3.2 Sungen Pharma Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.3.3 Sungen Pharma Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sungen Pharma Main Business Overview
13.3.5 Sungen Pharma Latest Developments
13.4 Hansoh Pharmaceutical
13.4.1 Hansoh Pharmaceutical Company Information
13.4.2 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.4.3 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hansoh Pharmaceutical Main Business Overview
13.4.5 Hansoh Pharmaceutical Latest Developments
13.5 CTTQ
13.5.1 CTTQ Company Information
13.5.2 CTTQ Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.5.3 CTTQ Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CTTQ Main Business Overview
13.5.5 CTTQ Latest Developments
13.6 Qilu Pharmaceutical
13.6.1 Qilu Pharmaceutical Company Information
13.6.2 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.6.3 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Qilu Pharmaceutical Main Business Overview
13.6.5 Qilu Pharmaceutical Latest Developments
13.7 Luoxin Pharmaceuticals
13.7.1 Luoxin Pharmaceuticals Company Information
13.7.2 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.7.3 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Luoxin Pharmaceuticals Main Business Overview
13.7.5 Luoxin Pharmaceuticals Latest Developments
13.8 Aosaikang Pharmaceutical
13.8.1 Aosaikang Pharmaceutical Company Information
13.8.2 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.8.3 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Aosaikang Pharmaceutical Main Business Overview
13.8.5 Aosaikang Pharmaceutical Latest Developments
13.9 jiuyuan gene engineering
13.9.1 jiuyuan gene engineering Company Information
13.9.2 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.9.3 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 jiuyuan gene engineering Main Business Overview
13.9.5 jiuyuan gene engineering Latest Developments
13.10 Sino Biopharmaceutical
13.10.1 Sino Biopharmaceutical Company Information
13.10.2 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.10.3 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Sino Biopharmaceutical Main Business Overview
13.10.5 Sino Biopharmaceutical Latest Developments
13.11 Sailong Pharmaceutical
13.11.1 Sailong Pharmaceutical Company Information
13.11.2 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
13.11.3 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sailong Pharmaceutical Main Business Overview
13.11.5 Sailong Pharmaceutical Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る